Toshiba Launches New ELERA™ Security Suite to Address the Industry’s Challenges Around Shrink
The new ELERA ™ Security Suite from Toshiba Global Commerce Solutions empowers retailers to minimize shrink while providing consumers with enhanced checkout experiences and reduced friction. According to the latest data from the National Retail Federation, retail shrink accounted for $94.5 billion in losses in 2021 in the U.S. and continues to be a critical challenge for retailers. Available later this year, the ELERA™ Security Suite offers retailers a comprehensive solution to protect their bottom line and combat multiple forms of shrink.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230912900113/en/
The A.I.-powered ELERA™ Security Suite offers retailers a comprehensive solution to minimize shrink while providing consumers with enhanced checkout experiences. (Photo: Business Wire)
“In a world where every second and every cent counts, ELERA™ Security Suite is not just a tool but a strategy—turning data into decisions and losses into profits,” said Yevgeni Tsirulnik, SVP of Innovation and Incubation at Toshiba Global Commerce Solutions. “As global leaders in retail solutions, our Toshiba team and partners came together to envision and develop the A.I.-powered ELERA™ Security Suite to enhance their loss prevention measures that have a direct and positive impact on retailer profits while also improving the shopper experience.”
The ELERA™ Security Suite end-to-end solution deployed as-a-service through Toshiba’s IoT platform, fully orchestrates computer vision cameras with advanced edge A.I., to enhance profit protections and shopper experiences through:
- Monitoring consumer behavior in real-time – without servers or processing lag – via TCx® EDGEcam+ and multiple sensors, which adds enhanced security throughout the checkout area
- Responding to incidents as they occur for more impactful and timely resolutions with leading A.I.-powered computer vision
- Notifying shoppers of potential errors through proactive alerts and allowing them to correct the issue themselves – minimizing employee intervention and improving the checkout experience
- Differentiating customer’s items vs. store items they’re purchasing, improving recognition accuracy, and reducing incorrect warnings
The modular ELERA™ Security Suite system empowers retailers with versatility and opportunities to leverage the latest technology to meet their business needs. The ELERA™ Security Suite can be part of the overall ELERA™ solution, or it can be attached to other Toshiba or third-party POS systems.
“We are excited to expand our collaboration with Toshiba Global Commerce Solutions by integrating the Qualcomm® QRB5165 System-on-Chip (SoC) for IoT into Toshiba’s TCx EDGEcam+ to provide one of the best A.I. edge processing platforms in the market,” stated Art Miller, Vice President, Business Development and Head of Retail and Payments, Qualcomm Technologies, Inc. “Qualcomm QRB5165 SoC brings distributed A.I. and compute capabilities to the edge eliminating the need for expensive and power-intensive servers in the back of the store.”
This A.I.-driven solution presents benefits to both retailers and consumers across multiple touchpoints. ELERA™ Security Suite expands on the previously available ELERA™ Produce Recognition that leverages A.I. and computer vision to accurately and efficiently identify produce and eliminate the need to input produce codes at checkout manually. Retailers are already benefiting from the produce recognition innovation through improved inventory accuracy and throughput in the self-service experience enabling a more seamless checkout and positive consumer experience. Based on recent retailer data, Toshiba has found that shoppers save as much as five seconds per produce item lookup during checkout.
Retailers that invest in the ELERA™ Security Suite can see strong returns on their investment in this new technology suite through increased inventory accuracy, decreased store staff intervention, and increased adoption of their self-checkout lanes. Given Toshiba’s focus on retailers and consumer privacy, we also offer peace of mind by meeting the requirements of applicable data privacy laws, including all federal, state, regional, territorial, national, and local laws, regulations, and rules by any government agency or authority that relate to the processing or the security of personal data.
Toshiba experts will be at GroceryShop 2023 in Las Vegas from September 19-21 to showcase the ELERA™ Security Suite and a portfolio of other retail solutions that enable retailers to re-imagine, accelerate, and differentiate their shopping experiences (booth #1050).
About Toshiba Global Commerce Solutions
Toshiba Global Commerce Solutions empowers retail to thrive and prosper through a dynamic ecosystem of smarter, more agile solutions and services that enable retailers to resiliently evolve with generations of consumers and adapt to market conditions. Supported by a global organization of devoted employees and partners, retailers gain more visibility and control over operations while enjoying the flexibility to build, scale, and transform retail experiences that anticipate and fulfill consumers’ ever-changing needs. Visit commerce.toshiba.com and engage with us on X, formerly known as Twitter, Facebook, LinkedIn, Instagram, and YouTube, to learn more.
Toshiba Global Commerce Solutions is a wholly owned subsidiary of Toshiba Tec Corporation, which is traded on the Tokyo Stock Exchange.
Qualcomm
Qualcomm is a trademark or registered trademark of Qualcomm incorporated. Qualcomm branded products are products of Qualcomm Technologies, Inc. and/or its subsidiaries. Qualcomm patented technologies are licensed by Qualcomm Incorporated.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230912900113/en/
Contact information
Toshiba Global Commerce Solutions
Elizabeth Romero
Director, Corporate Communications
elizabeth.romero@toshibagcs.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Axelspace: Notice of Signing a Service contract for In-Orbit Demonstration with Pale Blue, Inc.22.12.2025 11:00:00 EET | Press release
Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” has entered into a service agreement with Pale Blue Inc. (“Pale Blue”), a company that develops, manufactures, and sells thrusters (engines) for small satellites, for an in-orbit demonstration, as detailed below. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219321165/en/ Jun Asakawa, Co-founder & CEO of Pale Blue (left in photo) and Yuya Nakamura, President and CEO of Axelspace Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Under this contract, an in-orbit demonstration of a fast-start Hall thruster developed by Pale Blue is scheduled to be conducted in 2027. Nonetheless, conducting in-orbit demonstrations in a short period of time is known to be a significant challenge due to the in
Axelspace Signing Agreement on a Multi-Launch Arrangement and the Launch of New Satellites with Exolaunch22.12.2025 11:00:00 EET | Press release
Axelspace Corporation (“Axelspace”), a leading microsatellite company committed to making “Space within Your Reach,” is pleased to announce a multi-launch agreement (MLA) with Exolaunch, a global launch integrator and leader in launch mission management, satellite integration and satellite deployment technologies. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251219038364/en/ The Multi-Launch Agreement will accelerate the growth of Axelspace. In particular, one satellite scheduled for launch under the new Agreement will be used in the AxelLiner business’s in-orbit demonstration service, “AxelLiner Laboratory”. Exolaunch has already secured launches for eight (8) Axelspace’s satellites on the upcoming missions. Axelspace provides AxelLiner Laboratory (AL Lab), a new service originating from the AxelLiner business that is specialized in in-orbit demonstration of space components. Nonetheless, conducting in-orbit demonstration
Zambon Biotech Announces First Patient Dosed in Phase 3b ADIP Clinical Study of IPX203 in Parkinson’s Disease22.12.2025 11:00:00 EET | Press release
Zambon Biotech, a specialized biotech company part of the Zambon group that aims to build a scientifically robust and commercially viable portfolio of innovative patient-oriented drugs through the scouting, acquisition, licensing and development of new molecules, today announced that the first participant with advanced Parkinson’s disease has been enrolled in the European Phase 3b ADIP (IPX203 in Advanced Parkinson’s disease) study, which is planned to evaluate the efficacy and safety of IPX203 versus immediate-release (IR) levodopa/carbidopa (LD/CD) in a regimen which has not yet been the focus of a Phase 3 trial. IPX203 is a novel, oral modified-release formulation of LD/CD designed for the treatment of Parkinson’s disease, the fastest growing neurological condition in the world according to the World Health Organization1. IPX203 contains immediate-release granules and extended-release beads, providing both a rapid onset of action and a longer duration of benefit, sustaining the levo
Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor22.12.2025 10:00:00 EET | Press release
Merck, a leading science and technology company, announced today that following Priority Review, the China National Medical Products Administration (NMPA) has approved pimicotinib for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will potentially cause functional limitation or relatively severe morbidity. Pimicotinib, a colony stimulating factor-1 receptor (CSF-1R) inhibitor developed by Abbisko Therapeutics Co., Ltd., Shanghai, China, is the first Chemical Drug Class 1 approved in China for the treatment of TGCT. “We are continuing to deliver on our commitment to improving the lives of patients with rare tumors with this first-in-the-world regulatory approval of pimicotinib,” said Danny Bar-Zohar, CEO Healthcare and Member of the Executive Board of Merck. “This approval is a significant step forward in further strengthening our leadership in rare tumors, while offering patients the opportunity to change the course of
Incyte Japan Announces Approval of Minjuvi ® (tafasitamab) in Combination with Rituximab and Lenalidomide for the Treatment of Relapsed or Refractory Follicular Lymphoma22.12.2025 09:44:00 EET | Press release
Incyte Biosciences Japan G.K. today announced approval from Japan's Ministry of Health, Labour and Welfare (MHLW) for Minjuvi® (tafasitamab) in combination with rituximab and lenalidomide for adult patients with relapsed or refractory follicular lymphoma (2L+ FL). “Today's approval of Minjuvi in combination with rituximab and lenalidomide marks a significant milestone as the first dual-targeted CD19 and CD20 immunotherapy combination for relapsed or refractory FL in Japan,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “By improving progression-free survival, Minjuvi offers a chemotherapy-free option for eligible patients with relapsed or refractory disease. This approval underscores our commitment to bridging critical treatment gaps to patients and families affected by this challenging disease in Japan.” The approval is based on the pivotal Phase 3 inMIND trial, which enrolled 654 adult patients, including patients based in Japan. The study demonstrated that Minjuvi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
